Home › Hansa Medical develops second-generation IdeS molecules for repeat dosing
 

Keywords :   


Hansa Medical develops second-generation IdeS molecules for repeat dosing

2015-02-12 14:11:05| Appliances - Topix.net

Hansa Medical AB announced today that the company is developing a new generation of molecules based on IdeS that will allow repeat dosing and thereby broadening the therapeutic opportunities into more chronic disease areas. Since IdeS is a bacterial protein from Group A streptococcus the human immune system recognizes IdeS as foreign and reacts against the molecule.

Tags: medical repeat develops molecules

Category:Consumer Goods and Services

Latest from this category

All news
15.11Typhoo Tea teeters on the brink of administration
15.11Pre-Budget nerves blamed as UK growth slows
15.11Bitcoin hacker sentenced to five years in prison
15.11Europe's flying taxi dreams falter as cash runs short
14.11UK must rebuild post-Brexit relations with EU, says Bank boss
14.11'I spend 30 a week on baby milk because I can't breastfeed'
14.11The Onion buys Alex Jones's Infowars at auction
14.11The Onion buys Alex Jones's Infowars at auction
Consumer Goods and Services »
15.11Nintendo 3DSLL.DS lite.DS
15.11
15.11×142cm 3
15.11 selection5 5 3BOX
15.11 40T
15.11Knights
15.11 BIG
15.11 RE-TAKE 3
More »